Listed

Acadia Healthcare Company, Inc.

ACHCNasdaqCIK 1520697HealthcareFiscal year ends Dec 31

Reports and events: 300 filings

Newest first, by EDGAR acceptance time (Eastern). Each filing’s page lists its documents on sec.gov and, for 10-K and 10-Q reports, the extracted sections.

What the forms are: 10-K, 10-Q, 8-K, Form 4, DEF 14A, Schedule 13D, Schedule 13G, amendments, accession numbers.

Acadia Healthcare Company, Inc., Reports and events
FiledFormWhat it isAccession number
2023-11-0217:21 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0001157523-23-001637
2023-10-3016:50 ET8-K1.01 Entry into a material agreement; 9.01 Financial statements and exhibits0001193125-23-266248
2023-10-2616:15 ET8-K5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits0001193125-23-264094
2023-10-1117:09 ET8-K8.01 Other events0001193125-23-254205
2023-07-2816:06 ET10-QQuarterly reportPeriod 2023-06-300000950170-23-035484
2023-07-2716:10 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0001157523-23-001176
2023-07-1116:05 ET8-K8.01 Other events0001157523-23-001076
2023-07-0517:14 ET8-K5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits0001193125-23-182040
2023-06-0217:00 ET8-K5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits0001193125-23-159929
2023-05-1917:00 ET8-K5.02 Departure or appointment of officers or directors; 5.07 Shareholder vote results; 9.01 Financial statements and exhibits0001193125-23-149461
2023-04-2716:19 ET10-QQuarterly reportPeriod 2023-03-310000950170-23-015296
2023-04-2616:10 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0001157523-23-000620
2023-04-0716:01 ETDEF 14AProxy statement0001140361-23-017321
2023-02-2816:14 ET10-KAnnual reportPeriod 2022-12-310001564590-23-002737
2023-02-2716:10 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0001157523-23-000366
2022-12-0708:32 ET8-K7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits0001157523-22-001710
2022-11-0213:48 ET10-QQuarterly reportPeriod 2022-09-300001564590-22-036269
2022-11-0107:23 ET8-K/A2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits0001157523-22-001454
2022-10-3116:44 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0001157523-22-001443
2022-07-2816:45 ET10-QQuarterly reportPeriod 2022-06-300001564590-22-026910
2022-07-2716:52 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0001157523-22-000932
2022-06-2917:16 ET8-K5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits0001193125-22-185179
2022-05-2018:12 ET8-K5.07 Shareholder vote results0001193125-22-155213
2022-05-0416:27 ET10-QQuarterly reportPeriod 2022-03-310001564590-22-017872
2022-05-0316:11 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0001157523-22-000544
2022-04-0806:05 ETDEF 14AProxy statementPeriod 2022-05-190001140361-22-013667
2022-04-0417:03 ET8-K5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits0001157523-22-000389
2022-03-0113:06 ET10-KAnnual reportPeriod 2021-12-310001564590-22-007930
2022-02-2816:16 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0001157523-22-000270
2022-02-0116:05 ET8-K5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits0001193125-22-024575
2021-10-2916:06 ET10-QQuarterly reportPeriod 2021-09-300001564590-21-052945
2021-10-2816:32 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0001157523-21-001282
2021-10-0508:35 ET8-K5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits0001157523-21-001181
2021-08-0316:17 ET10-QQuarterly reportPeriod 2021-06-300001564590-21-040250
2021-08-0216:11 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0001157523-21-000964
2021-05-0717:02 ET8-K5.02 Departure or appointment of officers or directors; 5.07 Shareholder vote results; 9.01 Financial statements and exhibits0001193125-21-155064
2021-04-3016:18 ET10-QQuarterly reportPeriod 2021-03-310001564590-21-022545
2021-04-2916:10 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0001157523-21-000547
2021-03-2417:01 ETDEF 14AProxy statementPeriod 2021-05-060001193125-21-092741
2021-03-2208:46 ET8-K1.01 Entry into a material agreement; 1.02 Termination of a material agreement; 2.03 New direct financial obligation; 9.01 Financial statements and exhibits0001193125-21-088596
2021-02-2616:33 ET10-KAnnual reportPeriod 2020-12-310001564590-21-009466
2021-02-2617:37 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0001157523-21-000271
2021-01-2220:55 ET8-K5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits0001193125-21-013858
2021-01-2116:32 ET8-K2.01 Completion of an acquisition or disposition; 9.01 Financial statements and exhibits0001193125-21-013526
2021-01-0716:04 ET8-K1.01 Entry into a material agreement0001193125-21-004146
2020-12-3008:15 ET8-K1.01 Entry into a material agreement; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits0001193125-20-329213
2020-12-1117:14 ETSC 13D/AOwnership report, active investor, amended0001104659-20-134817
2020-11-1316:30 ET8-K1.01 Entry into a material agreement; 2.03 New direct financial obligation; 9.01 Financial statements and exhibits0001193125-20-293046
2020-10-3016:11 ET10-QQuarterly reportPeriod 2020-09-300001564590-20-049309
2020-10-2916:15 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0001157523-20-001384

Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Nov 4, 2026, 17:50 ET. Listed shows no prices and gives no investment advice.